A New Metabolite Panel Test for Identification of Patients with Impaired Glucose Tolerance? Analysis of the Article by Cobb Et Al
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The article by Cobb et al represents solid research work applying the most sophisticated laboratory technologies, a very sound clinical research methodology, and valid statistical analysis procedures. The authors have identified a combination of metabolites suitable to replace the oral glucose tolerance test procedure in the identification of patients with impaired glucose tolerance (IGT) from a fasting blood draw. However, the discussed pathophysiological, clinical, and economic aspects may induce mechanisms restricting the probability of a global acceptance of this test for daily routine.
References
1.
Cobb J, Eckhart A, Perichon R, Wulff J, Mitchell M, Adam K
. A novel test for IGT utilizing metabolite markers of glucose tolerance. J Diabetes Sci Technol. 2014; 9(1):69-76.
PMC: 4495543.
DOI: 10.1177/1932296814553622.
View
2.
Suhre K
. Metabolic profiling in diabetes. J Endocrinol. 2014; 221(3):R75-85.
DOI: 10.1530/JOE-14-0024.
View
3.
Pfutzner A, Pfutzner A, Larbig M, Forst T
. Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus. Diabetes Technol Ther. 2004; 6(3):405-12.
DOI: 10.1089/152091504774198124.
View
4.
Rossetti L, Giaccari A, DeFronzo R
. Glucose toxicity. Diabetes Care. 1990; 13(6):610-30.
DOI: 10.2337/diacare.13.6.610.
View
5.
Pradeepa R, Prabhakaran D, Mohan V
. Emerging economies and diabetes and cardiovascular disease. Diabetes Technol Ther. 2012; 14 Suppl 1:S59-67.
DOI: 10.1089/dia.2012.0065.
View